Fredun Pharmaceuticals fundamental analysis
FREDUN
1434.6
37.20 (-2.53%)Last updated on 21 Aug, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Fredun Pharmaceuticals Score Card
Price
Expensive
Growth
Good
Quality
Poor
Management
Good
On its scorecard, Fredun Pharmaceuticals reflects: Price – Expensive, Growth – Good, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Fredun Pharmaceuticals Associated Pages
- Fredun Pharmaceuticals
Share Price - Fredun Pharmaceuticals
Share Price chart - Fredun Pharmaceuticals
Technical Analysis - Fredun Pharmaceuticals
Peer Comparison - Fredun Pharmaceuticals
Share Price History - Fredun Pharmaceuticals
Dividend - Fredun Pharmaceuticals
Bonus Share - Fredun Pharmaceuticals
Board of Directors - Fredun Pharmaceuticals
Shareholding Pattern
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in FREDUN
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC